Cargando…

cGAMP the travelling messenger

2’3’-cGAMP is a key molecule in the cGAS-STING pathway. This cyclic dinucleotide is produced by the cytosolic DNA sensor cGAS in response to the presence of aberrant dsDNA in the cytoplasm which is associated with microbial invasion or cellular damage. 2’3’-cGAMP acts as a second messenger and activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Blest, Henry T. W., Chauveau, Lise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242147/
https://www.ncbi.nlm.nih.gov/pubmed/37287967
http://dx.doi.org/10.3389/fimmu.2023.1150705
_version_ 1785054150790217728
author Blest, Henry T. W.
Chauveau, Lise
author_facet Blest, Henry T. W.
Chauveau, Lise
author_sort Blest, Henry T. W.
collection PubMed
description 2’3’-cGAMP is a key molecule in the cGAS-STING pathway. This cyclic dinucleotide is produced by the cytosolic DNA sensor cGAS in response to the presence of aberrant dsDNA in the cytoplasm which is associated with microbial invasion or cellular damage. 2’3’-cGAMP acts as a second messenger and activates STING, the central hub of DNA sensing, to induce type-I interferons and pro-inflammatory cytokines necessary for responses against infection, cancer or cellular stress. Classically, detection of pathogens or danger by pattern recognition receptors (PRR) was thought to signal and induce the production of interferon and pro-inflammatory cytokines in the cell where sensing occurred. These interferon and cytokines then signal in both an autocrine and paracrine manner to induce responses in neighboring cells. Deviating from this dogma, recent studies have identified multiple mechanisms by which 2’3’-cGAMP can travel to neighboring cells where it activates STING independent of DNA sensing by cGAS. This observation is of great importance, as the cGAS-STING pathway is involved in immune responses against microbial invaders and cancer while its dysregulation drives the pathology of a wide range of inflammatory diseases to which antagonists have been elusive. In this review, we describe the fast-paced discoveries of the mechanisms by which 2’3’-cGAMP can be transported. We further highlight the diseases where they are important and detail how this change in perspective can be applied to vaccine design, cancer immunotherapies and treatment of cGAS-STING associated disease.
format Online
Article
Text
id pubmed-10242147
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102421472023-06-07 cGAMP the travelling messenger Blest, Henry T. W. Chauveau, Lise Front Immunol Immunology 2’3’-cGAMP is a key molecule in the cGAS-STING pathway. This cyclic dinucleotide is produced by the cytosolic DNA sensor cGAS in response to the presence of aberrant dsDNA in the cytoplasm which is associated with microbial invasion or cellular damage. 2’3’-cGAMP acts as a second messenger and activates STING, the central hub of DNA sensing, to induce type-I interferons and pro-inflammatory cytokines necessary for responses against infection, cancer or cellular stress. Classically, detection of pathogens or danger by pattern recognition receptors (PRR) was thought to signal and induce the production of interferon and pro-inflammatory cytokines in the cell where sensing occurred. These interferon and cytokines then signal in both an autocrine and paracrine manner to induce responses in neighboring cells. Deviating from this dogma, recent studies have identified multiple mechanisms by which 2’3’-cGAMP can travel to neighboring cells where it activates STING independent of DNA sensing by cGAS. This observation is of great importance, as the cGAS-STING pathway is involved in immune responses against microbial invaders and cancer while its dysregulation drives the pathology of a wide range of inflammatory diseases to which antagonists have been elusive. In this review, we describe the fast-paced discoveries of the mechanisms by which 2’3’-cGAMP can be transported. We further highlight the diseases where they are important and detail how this change in perspective can be applied to vaccine design, cancer immunotherapies and treatment of cGAS-STING associated disease. Frontiers Media S.A. 2023-05-23 /pmc/articles/PMC10242147/ /pubmed/37287967 http://dx.doi.org/10.3389/fimmu.2023.1150705 Text en Copyright © 2023 Blest and Chauveau https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Blest, Henry T. W.
Chauveau, Lise
cGAMP the travelling messenger
title cGAMP the travelling messenger
title_full cGAMP the travelling messenger
title_fullStr cGAMP the travelling messenger
title_full_unstemmed cGAMP the travelling messenger
title_short cGAMP the travelling messenger
title_sort cgamp the travelling messenger
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242147/
https://www.ncbi.nlm.nih.gov/pubmed/37287967
http://dx.doi.org/10.3389/fimmu.2023.1150705
work_keys_str_mv AT blesthenrytw cgampthetravellingmessenger
AT chauveaulise cgampthetravellingmessenger